NUTRINEAL PD4 cu 1,1% aminoacizi România - română - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

nutrineal pd4 cu 1,1% aminoacizi

baxter health care sa - irlanda - combinatii - sol. dial. perit. - preparate pentru dializa peritoneala solutii hipertone

MONIYOT-131 CAPSULE D România - română - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

moniyot-131 capsule d

monrol europe s.r.l. - natrii iodidum (131i) - caps. - 0,37-36mbq - tiroida preparate pentru radiodiagnostic la nivelul tiroidei, varia

MONIYOT-131 România - română - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

moniyot-131

monrol europe s.r.l. - ungaria - natrii iodidum (131i) - sol. orala pt. uz terapeutic - 14,8-3700mbq - alte radiofarmaceutice de uz terapeutic compusi cu iod 131

RABIPUR, vaccin rabic inactivat pentru uz uman România - română - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

rabipur, vaccin rabic inactivat pentru uz uman

gsk vaccines gmbh - vaccin rabic inactivat - pulb. liof. + solv. pt. sol. inj. i.d. - 2,5ui/ml - vaccinuri virale vaccinuri rabice

Comirnaty Uniunea Europeană - română - EMA (European Medicines Agency)

comirnaty

biontech manufacturing gmbh - single-stranded, 5’-capped messenger rna produced using a cell-free in vitro transcription from the corresponding dna templates, encoding the viral spike (s) protein of sars-cov-2 - covid-19 virus infection - vaccinuri - comirnaty 30 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older.  comirnaty 30 micrograms/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older.  comirnaty 10 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years.  comirnaty 3 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in infants and children aged 6 months to 4 years.  comirnaty original/omicron ba. 1 (15/15 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older who have previously received at least a primary vaccination course against covid-19. comirnaty original/omicron ba. 4-5 (15/15 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older. comirnaty original/omicron ba. 4-5 (5/5 micrograms)/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty original/omicron ba. 4-5 (5/5 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years.  comirnaty original/omicron ba. 4-5 (1. 5/1. 5 micrograms)/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in infants and children aged 6 months to 4 years.  comirnaty omicron xbb. 5 30 micrograms/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older. comirnaty omicron xbb. 5 10 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty omicron xbb. 5 10 micrograms/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty omicron xbb. 5 3 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in infants and children aged 6 months to 4 years. utilizarea acestui vaccin ar trebui să fie în conformitate cu recomandările oficiale.

Byfavo Uniunea Europeană - română - EMA (European Medicines Agency)

byfavo

paion deutschland gmbh - remimazolam besilate - sedarea conștientă - psiholeptice - remimazolam is indicated in adults for procedural sedation. remimazolam 50 mg is indicated in adults for intravenous induction and maintenance of general anaesthesia.

Brifan 1,5 mg/ml picături oftalmice, soluţie Republica Moldova - română - AMDM (Agenţia Medicamentului şi Dispozitivelor Medicale)

brifan 1,5 mg/ml picături oftalmice, soluţie

bilim ilac sanayi ve ticaret a.Ș. - brimonidinum - picături oftalmice, soluţie - 1,5 mg/ml

Virus-vaccin contra b.Newcastle, tulpina”La-Sota”-SPF Republica Moldova - română - ANSA (Agenţia Naţională pentru Siguranţa Alimentelor)

virus-vaccin contra b.newcastle, tulpina”la-sota”-spf

Îs din herson-fabrica biologică, ucraina - virusul - liofilizat - gaini, Курки, fazani, pauni, porumbei, bibilici

ELAPRASE 2mg/ml România - română - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

elaprase 2mg/ml

shire pharmaceuticals ireland limited - irlanda - idursulfasum - conc. pt. sol. perf. - 2mg/ml - alte produse pentru tractul digestiv si metabolism enzime